Roles of Albumin-Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery

Chembiochem. 2018 Sep 4;19(17):1796-1805. doi: 10.1002/cbic.201800201. Epub 2018 Jul 23.

Abstract

Nutrient transporters have attracted significant attention for their promising application in biomimetic delivery. Due to the active consumption of nutrients, cancer cells generally overexpress nutrient transporters to meet their increased need for energy and materials. For example, albumin-binding proteins (ABPs) are highly overexpressed in malignant cells, stromal cells, and tumor vessel endothelial cells responsible for albumin uptake. ABP (e.g., SPARC) is a promising target for tumor-specific drug delivery, and albumin has been widely used as a biomimetic delivery carrier. Apart from the transportation function, ABPs are closely associated with neoplasia, invasion, and metastasis. Herein, a summary of the roles of ABP in cancer progression and the application of albumin-based biomimetic tumor-targeted delivery through the ABP pathway is presented.

Keywords: albumin-binding proteins; biomimetic delivery; cancer; drug delivery; nutrient transporters.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Biomimetics / methods
  • Carrier Proteins / metabolism*
  • Carrier Proteins / physiology
  • Cell Line, Tumor
  • Drug Carriers / metabolism*
  • Glycoproteins / metabolism
  • Glycoproteins / physiology
  • Heterogeneous-Nuclear Ribonucleoproteins / metabolism
  • Heterogeneous-Nuclear Ribonucleoproteins / physiology
  • Humans
  • Nanoparticles / therapeutic use
  • Neoplasms / drug therapy*
  • Neoplasms / physiopathology
  • Receptors, Cell Surface / metabolism
  • Receptors, Cell Surface / physiology
  • Serum Albumin / metabolism*

Substances

  • Antineoplastic Agents
  • Carrier Proteins
  • Drug Carriers
  • Glycoproteins
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Receptors, Cell Surface
  • Serum Albumin